Health Care·Health Care Technology·$1.1B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.86 | N/A | -46.51% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.86 | N/A | -46.51% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management acknowledged the difficulties faced during the quarter. They remain committed to their strategic initiatives but did not provide specific guidance.
Management highlighted ongoing challenges in the market.
They emphasized a focus on long-term growth despite short-term setbacks.
Teladoc Health's earnings report reflects significant challenges, particularly with EPS missing expectations. Despite this, the stock rose slightly by 0.84%, indicating that investors may be optimistic about the company's long-term potential despite current hurdles. The lack of revenue data and guidance adds uncertainty moving forward.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
SOUTHERN COPPER CORP
Jul 26, 2021